GE HealthCare Technologies Inc.(GEHC US)
$82.60-1.051.26%
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions USD (ex. Per Share) | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1,618.0 | 2,050.0 | 2,154.0 | 1,964.0 | ||||||
| Depreciation & Amortization | 610.0 | 580.0 | 578.0 | 449.0 | ||||||
| Stock Based Compensation | 114.0 | 125.0 | 130.0 | 107.0 | ||||||
| Change in Working Capital | 22.0 | -59.0 | -357.0 | -247.0 | ||||||
| Other Non-Cash Items | -1,006.0 | -1,276.0 | -517.0 | -755.0 | ||||||
| Net Cash from Operating Activities | 2,101.0 | 1,951.0 | 1,988.0 | 2,028.0 | ||||||
| -Investments in Property, Plant & Equipment | -387.0 | -401.0 | -482.0 | -508.0 | ||||||
| -Acquisitions Net | -147.0 | -313.0 | - | -109.0 | ||||||
| -Purchases of Investments | -48.0 | -40.0 | -118.0 | -111.0 | ||||||
| Sales/Maturities of Investments | - | - | - | - | ||||||
| Other Investing Activities | 24.0 | -160.0 | -447.0 | -2,412.0 | ||||||
| Net Cash from Investing Activities | -558.0 | -914.0 | -1,047.0 | -3,140.0 | ||||||
| Net Debt Issuance | 1,139.0 | -423.0 | 967.0 | 1,371.0 | ||||||
| Net Stock Issuance | - | 33.0 | -163.0 | -178.0 | ||||||
| -Net Dividends Paid | -41.0 | -55.0 | -64.0 | -64.0 | ||||||
| Other Financing Activities | -1,576.0 | -128.0 | -123.0 | -205.0 | ||||||
| Net Cash from Financing Activities | -478.0 | -573.0 | 617.0 | 924.0 | ||||||
| Effect of Forex Changes | -10.0 | -77.0 | 64.0 | -1.0 | ||||||
| Net Change in Cash | 1,055.0 | 387.0 | 1,622.0 | -188.0 | ||||||
| Cash at End of Period | 2,506.0 | 2,893.0 | 4,515.0 | 14,596.0 | ||||||
| Operating Cash Flow | 2,101.0 | 1,951.0 | 1,988.0 | 2,028.0 | ||||||
| -Capital Expenditure | -387.0 | -401.0 | -482.0 | -508.0 | ||||||
| Free Cash Flow | 1,714.0 | 1,550.0 | 1,506.0 | 1,520.0 | ||||||
| Millions USD (ex. Per Share) | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1,618.0 | 2,050.0 | 2,154.0 | 1,964.0 | ||||||
| Depreciation & Amortization | 610.0 | 580.0 | 578.0 | 449.0 | ||||||
| Stock Based Compensation | 114.0 | 125.0 | 130.0 | 107.0 | ||||||
| Change in Working Capital | 22.0 | -59.0 | -357.0 | -247.0 | ||||||
| Other Non-Cash Items | -1,006.0 | -1,276.0 | -517.0 | -755.0 | ||||||
| Net Cash from Operating Activities | 2,101.0 | 1,951.0 | 1,988.0 | 2,028.0 | ||||||
| -Investments in Property, Plant & Equipment | -387.0 | -401.0 | -482.0 | -508.0 | ||||||
| -Acquisitions Net | -147.0 | -313.0 | - | -109.0 | ||||||
| -Purchases of Investments | -48.0 | -40.0 | -118.0 | -111.0 | ||||||
| Sales/Maturities of Investments | - | - | - | - | ||||||
| Other Investing Activities | 24.0 | -160.0 | -447.0 | -2,412.0 | ||||||
| Net Cash from Investing Activities | -558.0 | -914.0 | -1,047.0 | -3,140.0 | ||||||
| Net Debt Issuance | 1,139.0 | -423.0 | 967.0 | 1,371.0 | ||||||
| Net Stock Issuance | - | 33.0 | -163.0 | -178.0 | ||||||
| -Net Dividends Paid | -41.0 | -55.0 | -64.0 | -64.0 | ||||||
| Other Financing Activities | -1,576.0 | -128.0 | -123.0 | -205.0 | ||||||
| Net Cash from Financing Activities | -478.0 | -573.0 | 617.0 | 924.0 | ||||||
| Effect of Forex Changes | -10.0 | -77.0 | 64.0 | -1.0 | ||||||
| Net Change in Cash | 1,055.0 | 387.0 | 1,622.0 | -188.0 | ||||||
| Cash at End of Period | 2,506.0 | 2,893.0 | 4,515.0 | 14,596.0 | ||||||
| Operating Cash Flow | 2,101.0 | 1,951.0 | 1,988.0 | 2,028.0 | ||||||
| -Capital Expenditure | -387.0 | -401.0 | -482.0 | -508.0 | ||||||
| Free Cash Flow | 1,714.0 | 1,550.0 | 1,506.0 | 1,520.0 | ||||||